Table of Contents Author Guidelines Submit a Manuscript
Letter to the Editor
Dermatology Research and Practice
Volume 2014 (2014), Article ID 175693, 6 pages
http://dx.doi.org/10.1155/2014/175693
Research Article

Metabolic Changes and Serum Ghrelin Level in Patients with Psoriasis

1Department of Dermatology, Faculty of Medicine, Dicle University, 21070 Diyarbakir, Turkey
2Department of Dermatology, Faculty of Medicine, Firat University, Elazig, Turkey
3Department of Dermatology, Elazig Training and Research Hospital, Elazig, Turkey
4Department of Biochemistry, Faculty of Medicine, Firat University, Elazig, Turkey

Received 22 July 2014; Revised 2 December 2014; Accepted 8 December 2014; Published 18 December 2014

Academic Editor: Kiyofumi Yamanishi

Copyright © 2014 Haydar Ucak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Gelfand, R. Weinstein, S. B. Porter, A. L. Neimann, J. A. Berlin, and D. J. Margolis, “Prevalence and treatment of psoriasis in the United Kingdom: a population-based study,” Archives of Dermatology, vol. 141, no. 12, pp. 1537–1541, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. P. Schon and W. H. Boehncke, “Psoriasis,” The New England Journal of Medicine, vol. 352, pp. 1899–1912, 2005. View at Google Scholar
  3. T. Henseler and E. Christophers, “Disease concomitance in psoriasis,” Journal of the American Academy of Dermatology, vol. 32, no. 6, pp. 982–986, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Sommer, S. Jenisch, M. Suchan, E. Christophers, and M. Weichenthal, “Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis,” Archives of Dermatological Research, vol. 298, no. 7, pp. 321–328, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Zindanci, O. Albayrak, M. Kavala et al., “Prevalence of metabolic syndrome in patients with psoriasis,” The Scientific World Journal, vol. 2012, Article ID 312463, 5 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Gerkowicz, A. Pietrzak, J. C. Szepietowski, S. Radej, and G. Chodorowska, “Biochemical markers of psoriasis as a metabolic disease,” Folia Histochemica et Cytobiologica, vol. 50, no. 2, pp. 155–170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, “Ghrelin is a growth-hormone-releasing acylated peptide from stomach,” Nature, vol. 402, no. 6762, pp. 656–660, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Nakazato, N. Murakami, Y. Date et al., “A role for ghrelin in the central regulation of feeding,” Nature, vol. 409, no. 6817, pp. 194–198, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. V. D. Dixit, E. M. Schaffer, R. S. Pyle et al., “Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells,” The Journal of Clinical Investigation, vol. 114, no. 1, pp. 57–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Fredriksson and U. Pettersson, “Severe psoriasis—oral therapy with a new retinoid,” Dermatologica, vol. 157, no. 4, pp. 238–244, 1978. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Henseler and K. Schmitt-Rau, “A comparison between BSA, PASI, PLASI and SAPASI as measures of disease severity and improvement by therapy in patients with psoriasis,” International Journal of Dermatology, vol. 47, no. 10, pp. 1019–1023, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Öztürkcan, A. T. Ermertcan, E. Eser, and M. Turhan Şahin, “Cross validation of the Turkish version of dermatology life quality index,” International Journal of Dermatology, vol. 45, no. 11, pp. 1300–1307, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. P. I. Sidiropoulos, S. A. Karvounaris, and D. T. Boumpas, “Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications,” Arthritis Research and Therapy, vol. 10, article 207, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Kondo, M. Nomura, Y. Nakaya, S. Ito, and T. Ohguro, “Association of inflammatory marker and highly sensitive C-reactive protein with aerobic exercise capacity, maximum oxygen uptake and insulin resistance in healthy middle-aged volunteers,” Circulation Journal, vol. 69, no. 4, pp. 452–457, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. E. S. Ford, W. H. Giles, and W. H. Dietz, “Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey,” The Journal of the American Medical Association, vol. 287, no. 3, pp. 356–359, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Hu, Q. Qiao, J. Tuomilehto, B. Balkau, K. Borch-Johnsen, and K. Pyorala, “Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women,” Archives of Internal Medicine, vol. 164, no. 10, pp. 1066–1076, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. A. W. Armstrong, C. T. Harskamp, and E. J. Armstrong, “Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies,” Journal of the American Academy of Dermatology, vol. 68, no. 4, pp. 654–662, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. A. L. Neimann, D. B. Shin, X. Wang, D. J. Margolis, A. B. Troxel, and J. M. Gelfand, “Prevalence of cardiovascular risk factors in patients with psoriasis,” Journal of the American Academy of Dermatology, vol. 55, no. 5, pp. 829–835, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome,” The Lancet, vol. 365, no. 9468, pp. 1415–1428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. The IDF consensus worldwide definition of the metabolic syndrome, 2011, http://www.idf.org/webdata/docs/MetSyndrome_FINAL.pdf.
  21. D. M. Sommer, S. Jenisch, M. Suchan, E. Christophers, and M. Weichenthal, “Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis,” Archives of Dermatological Research, vol. 298, no. 7, pp. 321–328, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Naldi, L. Chatenoud, D. Linder et al., “Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study,” Journal of Investigative Dermatology, vol. 125, no. 1, pp. 61–67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Gisondi, G. Tessari, A. Conti et al., “Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study,” British Journal of Dermatology, vol. 157, no. 1, pp. 68–73, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. J. S. Yudkin, C. D. A. Stehouwer, J. J. Emeis, and S. W. Coppack, “C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 4, pp. 972–978, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Nakajima, K. Nakajima, M. Tarutani, and S. Sano, “The role of pigment epithelium-derived factor as an adipokine in psoriasis,” Archives of Dermatological Research, vol. 304, no. 1, pp. 81–84, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Ghelardoni, V. Carnicelli, S. Frascarelli, S. Ronca-Testoni, and R. Zucchi, “Ghrelin tissue distribution: comparison between gene and protein expression,” Journal of Endocrinological Investigation, vol. 29, no. 2, pp. 115–121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Özdemir, M. Yüksel, H. Gökbel, N. Okudan, and I. Mevlitoǧlu, “Serum leptin, adiponectin, resistin and ghrelin levels in psoriatic patients treated with cyclosporin,” Journal of Dermatology, vol. 39, no. 5, pp. 443–448, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. V. D. Dixit, E. M. Schaffer, R. S. Pyle et al., “Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells,” The Journal of Clinical Investigation, vol. 114, no. 1, pp. 57–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. Q. Xia, W. Pang, H. Pan, Y. Zheng, J.-S. Kang, and S.-G. Zhu, “Effects of ghrelin on the proliferation and secretion of splenic T lymphocytes in mice,” Regulatory Peptides, vol. 122, no. 3, pp. 173–178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. O. Arican, M. Aral, S. Sasmaz, and P. Ciragil, “Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity,” Mediators of Inflammation, vol. 2005, no. 5, pp. 273–279, 2005. View at Publisher · View at Google Scholar · View at Scopus